AAV

Aug 11, 2020

StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer

Apr 01, 2020

Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!

Feb 24, 2020

Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)

Jan 13, 2020

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

Nov 19, 2019

AskBio Receives "Best Venture Funding" Award from Southeast BIO

Apr 15, 2019

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2019 Annual Meeting

Jan 31, 2019

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

Jan 03, 2019

StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Officer

Apr 16, 2018

Vigene Biosciences Announces Partnership With Virovek to Make High-Yield cGMP AAV Production Technology Accessible and Affordable

Apr 15, 2018

Advantage Announces Executive Appointment Vice President Marketing & Commercial